Neale Cohen - Academia.edu (original) (raw)

Related Authors

Yuksel  Goktas

David Pierre Leibovitz

Daniel  Cassany

David Seamon

Flavio Escribano

Leticia Cesarino

Leticia Cesarino

Universidade Federal de Santa Catarina - UFSC (Federal University of Santa Catarina)

Niki  Nikonanou

Stefania Savva

Panas Karampampas

Mariia Protsiuk

Uploads

Papers by Neale Cohen

Research paper thumbnail of Different frequencies of active interruptions to sitting have distinct effects on 22 h glycemic control in type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases, 2021

This is a PDF file of an article that has undergone enhancements after acceptance, such as the ad... more This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Research paper thumbnail of Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study

Diabetes Research and Clinical Practice, 2017

Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet ... more Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study Melinda J CARRINGTON a, b |

Research paper thumbnail of Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis

Acta Diabetologica, 2010

Continuous subcutaneous insulin infusion (CSII) is considered an option for type 1 diabetic patie... more Continuous subcutaneous insulin infusion (CSII) is considered an option for type 1 diabetic patients unsatisfactorily controlled with multiple daily injections (MDI). Short-acting analogs are superior to regular human insulin in CSII. This meta-analysis is aimed at assessing the advantages of short-acting analog-based CSII over MDI in type 1 diabetes. Randomized clinical trials (RCTs) comparing CSII (with analogs) and MDI for

Research paper thumbnail of Different frequencies of active interruptions to sitting have distinct effects on 22 h glycemic control in type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases, 2021

This is a PDF file of an article that has undergone enhancements after acceptance, such as the ad... more This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Research paper thumbnail of Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study

Diabetes Research and Clinical Practice, 2017

Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet ... more Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study Melinda J CARRINGTON a, b |

Research paper thumbnail of Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis

Acta Diabetologica, 2010

Continuous subcutaneous insulin infusion (CSII) is considered an option for type 1 diabetic patie... more Continuous subcutaneous insulin infusion (CSII) is considered an option for type 1 diabetic patients unsatisfactorily controlled with multiple daily injections (MDI). Short-acting analogs are superior to regular human insulin in CSII. This meta-analysis is aimed at assessing the advantages of short-acting analog-based CSII over MDI in type 1 diabetes. Randomized clinical trials (RCTs) comparing CSII (with analogs) and MDI for

Log In